Sanofi Consumer Healthcare started the journey for North America in November 2021 conducting a comprehensive assessment of the social and environmental impact of the company through the use of B Impact Assessment (BIA). They delved into every aspect of the organisation, from supply chain to employee welfare, environmental sustainability to community engagement.
Following a three-year process, the Jersey-based company achieved a B Impact score of 85, with 80 the required ‘pass rate’ to achieve B Corp Certification, and 50.9 the median score.
The maker of brands such as Allegra, Dulcolax, Icy Hot, Unisom and Xyzal, the company says this is a great start, but a score they are looking to improve across the five key pillars of performance and responsibility – Governance, Workers, Community, Environment, Customers.
So how did Sanofi achieve its B Corp status? Here are some highlights, and wider ambitions:
- Reduced Scope 1 and Scope 2 greenhouse gas emissions at its manufacturing site by 77% in 2022 vs 2019 – part of the path to being carbon neutral by 2030 and net zero by 2045. The company is replacing fossil fuels with biomass, biogas or through process electrification
- Powers its North American manufacturing and distribution site with 100% renewable electricity since 2020 – part of the goal to achieve 100% renewables by 2025 for all manufacturing operations globally
- Reached 41% representation of women in senior leadership roles – goal is to reach 50/50 gender parity in senior leadership positions by 2025
- Provides access to sports opportunities for Canadian youth facing socio-economic barriers – aim is to reach 5 million people by 2030
- Eliminating 35 tons of plastic packaging per year by removing plastic windows on selected products – reducing the environmental footprint of products and increasing packaging recyclability
In June, Sanofi is also accelerating efforts to reach net zero emissions across all operations (scope 1 & 2) and the entire value chain (scope 3) by 2045 – bringing forward this milestone by 5 years. The new target is based on Science Based Targets initiative (SBTi) as well Sanofi’s updated scope 3 reduction target of achieving a reduction of 30% GHG emissions by 2030.
“We know that healthier people and a healthy planet go hand in hand,” says Loucks. “We’re proud of the progress we’ve made in our journey to create a business that does well while doing good.”
link
